Squarepoint’s Jaguar Health JAGX Stock Holding History

Squarepoint’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-28	Closed	-$80.9K	–	4395
2024 Q2	$80.9K	Buy	+28	New	+$185K	﹤0.01%	3838
2021 Q2	–	Hold	0	–	-$116K	–	3459
2021 Q1	–	Hold	0	–	–	–	2864

Other funds holding JAGX

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Squarepoint's JAGX Position: Q3 2024 in Review

Squarepoint sold out of Jaguar Health (JAGX) in Q3 2024, closing a stake of 28 shares — an estimated $80.9K sold.

Squarepoint first reported a position in JAGX in Q2 2024 and held it in 1 quarter. The position peaked at $80.9K in Q2 2024. 9 funds tracked by Wall St. Rank hold JAGX as of Q3 2024.

Squarepoint reported no remaining Jaguar Health position as of Q3 2024 after selling out during the quarter.
Squarepoint sold 28 Jaguar Health shares in Q3 2024, an estimated $80.9K.
Squarepoint first reported a position in Jaguar Health in Q2 2024 and held it in 1 quarter.
Squarepoint's Jaguar Health position peaked at $80.9K in Q2 2024.
9 funds tracked by Wall St. Rank held Jaguar Health as of Q3 2024.

Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.